Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development.

During vascular development, endothelial platelet-derived growth factor B (PDGF-B) is critical for pericyte recruitment. Deletion of the conserved C-terminal heparin-binding motif impairs PDGF-BB retention and pericyte recruitment in vivo, suggesting a potential role for heparan sulfate (HS) in PDGF-BB function during vascular development. We studied the participation of HS chains in pericyte recruitment using two mouse models with altered HS biosynthesis. Reduction of N-sulfation due to deficiency in N-deacetylase/N-sulfotransferase-1 attenuated PDGF-BB binding in vitro, and led to pericyte detachment and delayed pericyte migration in vivo. Reduced N-sulfation also impaired PDGF-BB signaling and directed cell migration, but not proliferation. In contrast, HS from glucuronyl C5-epimerase mutants, which is extensively N- and 6-O-sulfated, but lacks 2-O-sulfated L-iduronic acid residues, retained PDGF-BB in vitro, and pericyte recruitment in vivo was only transiently delayed. These observations were supported by in vitro characterization of the structural features in HS important for PDGF-BB binding. We conclude that pericyte recruitment requires HS with sufficiently extended and appropriately spaced N-sulfated domains to retain PDGF-BB and activate PDGF receptor beta (PDGFRbeta) signaling, whereas the detailed sequence of monosaccharide and sulfate residues does not appear to be important for this interaction.

[1]  Ulf Landegren,et al.  Sensitive protein detection via triple-binder proximity ligation assays , 2007, Nature Methods.

[2]  M. Pardue,et al.  The Journal of Cell Biology , 2002 .

[3]  J. Kreuger,et al.  Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. , 2006, Developmental cell.

[4]  D. Spillmann,et al.  3-O-Sulfated Oligosaccharide Structures Are Recognized by Anti-heparan Sulfate Antibody HS4C3* , 2006, Journal of Biological Chemistry.

[5]  Christopher J. Robinson,et al.  VEGF165-binding Sites within Heparan Sulfate Encompass Two Highly Sulfated Domains and Can Be Liberated by K5 Lyase* , 2006, Journal of Biological Chemistry.

[6]  T. Hata,et al.  Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. , 2005, Glycobiology.

[7]  J. Esko,et al.  Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function , 2005, Development.

[8]  N. Perrimon,et al.  Developmental cell biology: Heparan sulphate proteoglycans: the sweet side of development , 2005, Nature Reviews Molecular Cell Biology.

[9]  J. van den Born,et al.  Novel Heparan Sulfate Structures Revealed by Monoclonal Antibodies* , 2005, Journal of Biological Chemistry.

[10]  Xinhua Lin,et al.  Functions of heparan sulfate proteoglycans in cell signaling during development , 2004, Development.

[11]  L. Kjellén,et al.  Heparan Sulfate Synthesized by Mouse Embryonic Stem Cells Deficient in NDST1 and NDST2 Is 6-O-Sulfated but Contains No N-Sulfate Groups* , 2004, Journal of Biological Chemistry.

[12]  Johan Ledin,et al.  Heparan Sulfate Structure in Mice with Genetically Modified Heparan Sulfate Production* , 2004, Journal of Biological Chemistry.

[13]  C. Betsholtz Insight into the physiological functions of PDGF through genetic studies in mice. , 2004, Cytokine & growth factor reviews.

[14]  Minoru Takemoto,et al.  Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities , 2004, Development.

[15]  A. Rapraeger,et al.  Syndecans in tumor cell adhesion and signaling , 2004, Reproductive biology and endocrinology : RB&E.

[16]  Philippe Soriano,et al.  Additive Effects of PDGF Receptor β Signaling Pathways in Vascular Smooth Muscle Cell Development , 2003, PLoS biology.

[17]  C. Betsholtz,et al.  Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. , 2003, The Journal of clinical investigation.

[18]  U. Landegren,et al.  Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. , 2003, Genes & development.

[19]  M. Åbrink,et al.  Targeted Disruption of a Murine Glucuronyl C5-epimerase Gene Results in Heparan Sulfate Lacking l-Iduronic Acid and in Neonatal Lethality* , 2003, Journal of Biological Chemistry.

[20]  Holger Gerhardt,et al.  Endothelial-pericyte interactions in angiogenesis , 2003, Cell and Tissue Research.

[21]  K. Alitalo,et al.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.

[22]  H. Hammes,et al.  Pericytes and the Pathogenesis of Diabetic Retinopathy , 2005, Diabetes.

[23]  J. Esko,et al.  Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes. , 2002, Biochimica et biophysica acta.

[24]  R. Timpl,et al.  Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function , 2002, The EMBO journal.

[25]  J. Esko,et al.  Variant heparan sulfates synthesized in developing mouse brain differentially regulate FGF signaling. , 2002, Glycobiology.

[26]  Holger Gerhardt,et al.  Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. , 2002, Genes & development.

[27]  P. Jemth,et al.  Biosynthetic Oligosaccharide Libraries for Identification of Protein-binding Heparan Sulfate Motifs , 2002, The Journal of Biological Chemistry.

[28]  H. Hammes,et al.  Endothelium‐specific platelet‐derived growth factor‐B ablation mimics diabetic retinopathy , 2002, The EMBO journal.

[29]  J. Turnbull,et al.  Fibroblast Growth Factor Receptors 1 and 2 Interact Differently with Heparin/Heparan Sulfate , 2002, The Journal of Biological Chemistry.

[30]  L. Claesson‐Welsh,et al.  Heparin Amplifies Platelet-derived Growth Factor (PDGF)- BB-induced PDGF α-Receptor but Not PDGF β-Receptor Tyrosine Phosphorylation in Heparan Sulfate-deficient Cells , 2002, The Journal of Biological Chemistry.

[31]  Kenneth M. Yamada,et al.  Integrin regulation of growth factor receptors , 2002, Nature Cell Biology.

[32]  S. Selleck,et al.  Order out of chaos: assembly of ligand binding sites in heparan sulfate. , 2002, Annual review of biochemistry.

[33]  B. Ramsahoye Nearest-neighbor analysis. , 2002, Methods in molecular biology.

[34]  J. Gallagher Heparan sulfate: growth control with a restricted sequence menu. , 2001, The Journal of clinical investigation.

[35]  J. Esko,et al.  Molecular diversity of heparan sulfate. , 2001, The Journal of clinical investigation.

[36]  T. V. van Kuppevelt,et al.  Defective Heparan Sulfate Biosynthesis and Neonatal Lethality in Mice LackingN-Deacetylase/N-Sulfotransferase-1* , 2000, The Journal of Biological Chemistry.

[37]  A. Woods,et al.  Syndecan-4 and integrins: combinatorial signaling in cell adhesion. , 1999, Journal of cell science.

[38]  L. Hellman,et al.  Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme , 1999, Nature.

[39]  C. Betsholtz,et al.  Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.

[40]  U. Hedin,et al.  Heparan sulfate proteoglycans mediate a potent inhibitory signal for migration of vascular smooth muscle cells. , 1998, Circulation research.

[41]  D. Spillmann,et al.  Defining the Interleukin-8-binding Domain of Heparan Sulfate* , 1998, The Journal of Biological Chemistry.

[42]  D. Spillmann,et al.  Structural Requirement of Heparan Sulfate for Interaction with Herpes Simplex Virus Type 1 Virions and Isolated Glycoprotein C* , 1997, The Journal of Biological Chemistry.

[43]  S. Stringer,et al.  Specific Binding of the Chemokine Platelet Factor 4 to Heparan Sulfate* , 1997, The Journal of Biological Chemistry.

[44]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[45]  D. Spillmann,et al.  Characterization of Heparin and Heparan Sulfate Domains Binding to the Long Splice Variant of Platelet-derived Growth Factor A Chain* , 1997, The Journal of Biological Chemistry.

[46]  G. Bondjers,et al.  Alternative splicing determines the binding of platelet-derived growth factor (PDGF-AA) to glycosaminoglycans. , 1996, Biochemistry.

[47]  J. Turnbull,et al.  Molecular organization of the interferon gamma-binding domain in heparan sulphate. , 1995, The Biochemical journal.

[48]  S. Aaronson,et al.  A novel mechanism regulating growth factor association with the cell surface: identification of a PDGF retention domain. , 1991, Genes & Development.

[49]  C. Heldin,et al.  Identification of a cell retention signal in the B-chain of platelet-derived growth factor and in the long splice version of the A-chain. , 1991, Cell regulation.

[50]  O. Yoshie,et al.  A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1. , 1986, Journal of immunology.

[51]  M. Höök,et al.  N-[3H]Acetyl-labeling, a convenient method for radiolabeling of glycosaminoglycans. , 1982, Analytical biochemistry.

[52]  C. He,et al.  Nearest neighbor analysis of heparin: identification and quantitation of the products formed by selective depolymerization procedures. , 1976 .